These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

920 related articles for article (PubMed ID: 33602220)

  • 21. Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer.
    Li X; Xie M; Yin S; Xiong Z; Mao C; Zhang F; Chen H; Jin L; Lan P; Lian L
    Front Genet; 2021; 12():666003. PubMed ID: 34017356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
    Shen R; Liu B; Li X; Yu T; Xu K; Ma J
    BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
    Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
    Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
    [No Abstract]   [Full Text] [Related]  

  • 24. Expression Profile Analysis Identifies a Novel Seven Immune-Related Gene Signature to Improve Prognosis Prediction of Glioblastoma.
    Hu L; Han Z; Cheng X; Wang S; Feng Y; Lin Z
    Front Genet; 2021; 12():638458. PubMed ID: 33708242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eleven inflammation-related genes risk signature model predicts prognosis of patients with breast cancer.
    Hu H; Yuan S; Fu Y; Li H; Xiao S; Gong Z; Zhong S
    Transl Cancer Res; 2024 Jul; 13(7):3652-3667. PubMed ID: 39145071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of an immune-related gene signature to predict survival and treatment outcome in gastric cancer.
    Zhang S; Li Z; Dong H; Wu P; Liu Y; Guo T; Li C; Wang S; Qu X; Liu Y; Che X; Xu L
    Sci Prog; 2021; 104(1):36850421997286. PubMed ID: 33661721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
    Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
    Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis of a new immune-related prognostic signature for esophageal cancer and its correlation with infiltrating immune cells and target genes.
    Peng Z; Liu XY; Cheng Z; Kai W; Song Z
    Ann Transl Med; 2021 Oct; 9(20):1576. PubMed ID: 34790782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel immune prognostic model in gastric cancer.
    Li Y; He X; Fan L; Zhang X; Xu Y; Xu X
    Clin Transl Oncol; 2021 Apr; 23(4):846-855. PubMed ID: 32857339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of an immune-related gene signature and infiltrating tumor immune cells based on bioinformatics analysis in primary esophageal cancer.
    Du H; Pang S; Li Y; Zhu L; Hang J; Chen L
    J Gastrointest Oncol; 2022 Aug; 13(4):1556-1570. PubMed ID: 36092327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of an Innate Immune-Related Prognostic Signature in Early-Stage Lung Squamous Cell Carcinoma.
    Li L; Yu X; Ma G; Ji Z; Bao S; He X; Song L; Yu Y; Shi M; Liu X
    Int J Gen Med; 2021; 14():9007-9022. PubMed ID: 34876838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune-related gene signature predicts overall survival of gastric cancer patients with varying microsatellite instability status.
    Tian R; Hu J; Ma X; Liang L; Guo S
    Aging (Albany NY); 2020 Dec; 13(2):2418-2435. PubMed ID: 33316777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
    Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
    Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of an immune-related gene prognostic model for head and neck tumors.
    Zhou F; Chen AX; Lv HY; Liang DH; Yu HS
    J Biol Regul Homeost Agents; 2021; 35(3):975-986. PubMed ID: 34159769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem cell-associated signature for estimating prognosis and drug sensitivity in gastric cancer.
    Shen K; Chen B; Gao W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11829-11847. PubMed ID: 37410142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel predictive model incorporating immune-related gene signatures for overall survival in melanoma patients.
    Liao M; Zeng F; Li Y; Gao Q; Yin M; Deng G; Chen X
    Sci Rep; 2020 Jul; 10(1):12462. PubMed ID: 32719391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and external validation of a prognostic signature associated with DNA repair genes in gastric cancer.
    Chen S; Liu W; Huang Y
    Sci Rep; 2021 Mar; 11(1):7141. PubMed ID: 33785812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
    Liang X; Cheng Z; Chen X; Li J
    Front Genet; 2022; 13():955424. PubMed ID: 36046241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.